Table 4.
Summary of base cases results.
Cost results, $ | LY | QALY | ICER | |||||
---|---|---|---|---|---|---|---|---|
Total | Incremental | Total | Incremental | Total | Incremental | per LY | per QALY | |
Total | ||||||||
GP | 37,368.55 | 3,821.99 | 8.10 | 0.67 | 5.66 | 0.42 | 5,704.46 | 9,099.98 |
TPF | 33,546.56 | – | 7.43 | – | 5.24 | – | – | – |
DFS state | ||||||||
GP | 18,909.36 | – | 5.51 | 0.22 | 4.19 | 0.17 | ||
TPF | 19,930.34 | 1,020.98 | 5.29 | – | 4.02 | – | Dominated | Dominated |
PD state | ||||||||
GP | 18,459.19 | 4,842.97 | 2.59 | 0.45 | 1.47 | 0.25 | 10762.16 | 19,371.88 |
TPF | 13,616.22 | – | 2.14 | – | 1.22 | – |
ICER, incremental cost-effectiveness ratio; LY, life year; QALY, quality-adjusted life-year.